Published in Cancer Weekly, March 21st, 2000
This cancer vaccine technology was developed by Donald Kufe, MD, professor of medicine, and Jianlin Gong, MD, instructor of medicine, both at the Dana-Farber Cancer Institute and Harvard Medical School.
In March 2000, data from a German clinical study of a cancer vaccine to treat metastatic renal cancer (kidney cancer) based on Kufe's and Gong's concept of dendritic/cancer cell fusion were published in Nature Medicine (2000;6(3):332-336). The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.